Autoimmune Disease Diagnostics Market size worth $15bn by 2023

Autoimmune Disease Diagnostics Market size is estimated to reach USD 15.7 billion by 2023; as per a new research report by Global Market Insights, Inc. Rising lab automation rates enabling faster and precise diagnosis in order to cater the increasing procedure volumes, and introduction of technologically advanced products should spur the global autoimmune disease diagnostics market size.

The U.S. autoimmune diagnostics market dominated North America, exceeding USD 3.5 billion by 2023. The U.S. population showcases high prevalence of autoimmune diseases, with heightened awareness levels leading to more diagnosis.

The autoimmune disease diagnostics industry is predominantly driven by the presence of favorable initiatives aimed at enhancing patient awareness, increased R&D funding, and target disease prevalence with consequent rise in number of tests.

Request for a sample of this research report - http://bit.ly/2eg7VII

Various initiatives are being taken to curb the rising autoimmune disease prevalence. According to NIH Autoimmune Disease Coordinating Committee (ADCC), autoimmune diseases affect around 14 to 22 million people in the U.S. causing a significant amount of emotional, social, and financial burden to the country’s health care system. For instance, annual medical costs for treating multiple sclerosis have been estimated to be $2.5 billion, which is even higher than cost for treating diabetes. Citing this, the government has shifted its focus on curbing and treating autoimmune diseases, leading to a rise in demand for diagnostics.

Make an inquiry for purchasing this report @ http://bit.ly/2egCyfY

The federal planning for autoimmune diseases research includes the formation of The NIH Autoimmune Diseases Coordinating Committee (ADCC), that coordinates autoimmune diseases research work of the U.S. Food and Drug Administration (FDA), Department of Veterans Affairs (VA), National Institutes of Health, the Centers for Disease, Control and Prevention (CDC), and private organizations.

Browse key industry insights spread across 82 pages with 30 market data tables & 28 figures & charts from the report, “Autoimmune Disease Diagnostics Market Size By Product [Systemic (Rheumatoid Arthritis, Ankylosing Spondylitis, Systemic Lupus Erythematosus (SLE)), Localized], Industry Analysis Report, Regional Outlook (U.S., Canada, Germany, U.K, Japan, China, Brazil) Application Potential, Price Trends, Competitive Market Share & Forecast, 2016 – 2023” in detail along with the table of contents:

http://bit.ly/2ejyZ7b

Key insights from the report include:

• Global autoimmune disease diagnostics market size was pegged at USD 12.8 billion in 2015, and projected to reach USD 15.7 billion by 2023, at an estimated CAGR of 2.6% from 2016 to 2023.

• Europe autoimmune disease diagnostics industry should show steady growth, with Germany, and UK being key revenue contributors, with more than 30% of total 2015 regional revenue.

• Growing prevalence due to low awareness levels in Asia-Pacific should offer potential growth for the autoimmune disease diagnostics market. The region is slated to witness highest CAGR of 5.3% from 2016 to 2023. China and Japan are the major revenue pockets.

• With various small and local players competing on the basis of price, there is some degree of fragmentation on a domestic level. However, large capital expenditure is required in case of lab automation technology oriented manufacturing.

• Introduction of innovative technologically advanced products such as Celiac Panel Test by SQI Diagnostics that enables faster IgG & IgA antibodies detection, and customized time saving, multifunctional kits such as ImmunoSEQtime should further contribute to the industry growth.

Global Market Insights, Inc., headquartered in Delaware, U.S., is a global market research and consulting service provider; offering syndicated and custom research reports along with growth consulting services. Our business intelligence and industry research reports offer clients with penetrative insights and actionable market data specially designed and presented to aid strategic decision making. These exhaustive reports are designed via a proprietary research methodology and are available for key industries such as chemicals, advanced materials, technology, renewable energy and biotechnology.

Corporate Sales, USA
Global Market Insights, Inc.
Phone: 1-302-846-7766
Toll Free: 1 888-689-0688
Email: sales@gminsights.com
Web: https://www.gminsights.com

This release was published on openPR.